服务热线
021-60498804
| Cat. Number | A6979 |
| Chemical Name | 双氢青蒿素 Dihydroartemisinin |
| CAS Number | 71939-50-9 |
| Mol. Formula | C15H24O5 |
| Mol. Weight | 284.35 |
| Qty 1 |
50mg |
| Qty 2 | 100mg |
| Appearance | White Crystal Powder |
| Application Notes | ≥96% |
| Synonym | Dihydroartemisinine, Dihydroqinghaosu, (3R,5aS,6R,8aS,9R,10S,12R,12aR)-Decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10- ol |
| Melting Pt. | 140°C |
| Solubility | Insoluble in water. Soluble in acetone and ethanol. |
| Storage condition | Ambient |
| References | Dihydroartemisinin is a sesquiterpene lactone that can be derived from Artemisia. Dihydroartemisinin exhibits anticancer, antiviral, anti-inflammatory, anti-asthma, and anti-parasitic activities. Artemisinins such as dihydroartemisinin are best known for their antimalarial activity. Dihydroartemisinin induces apoptosis in colorectal cancer cells, increasing levels of ROS and Bax; it also inhibits mTORC1 in rhabdomyosarcoma cells. Dihydroartemisinin displays antimicrobial activity against Plasmodium, Schistosoma, and human cytomegalovirus. This compound also decreases levels of inflammatory cells, Th2 cytokines, IgE, and mucus secretion, suppressing airway hyper-responsiveness in animal models of asthma. 参考文献： Ontikatze T, Rudner J, Handrick R, et al. Dihydroartemisinin is a Hypoxia-Active Anti-Cancer Drug in Colorectal Carcinoma Cells. Front Oncol. 2014 May 19;4:116. PMID: 24904829. Wanzira H, Kakuru A, Arinaitwe E, et al. Longitudinal Outcomes in a Cohort of Ugandan Children Randomized to Artemether-lumefantrine Versus Dihydroartemisinin-piperaquine for the Treatment of Malaria. Clin Infect Dis. 2014 May 13. [Epub ahead of print]. PMID: 24825870. Li HJ, Xu FL, Wang YH, et al. Dihydroartemisinin: a new story of an old drug against Schistosoma mansoni infection. Parasitol Res. 2014 Jan;113(1):239-41. PMID: 24146209. Flobinus A, Taudon N, Desbordes M, et al. Stability and antiviral activity against human cytomegalovirus of artemisinin derivatives. J Antimicrob Chemother. 2014 Jan;69(1):34-40. PMID: 24003183. Odaka Y, Xu B, Luo Y, et al. Dihydroartemisinin inhibits the mammalian target of rapamycin-mediated signaling pathways in tumor cells. Carcinogenesis. 2014 Jan;35(1):192-200. PMID: 23929438. |
Copyright © 2022 上海惠诚生物科技有限公司
沪ICP备2021037845号-6
